BBL
CLB icon

Beck Bode LLC’s Core Laboratories CLB Stock Holding History

Beck Bode LLC’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-219,503
Closed -$4.84M – 145
2023
Q1 		$4.84M Buy
+219,503
New +$5.14M 1.19% 24
2020
Q4 		– Sell
-606
Closed -$9K – 51
2020
Q3 		$9K Buy
+606
New +$12.7K ﹤0.01% 211

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Beck Bode LLC's CLB Position: Q2 2023 in Review

Beck Bode LLC sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 219,503 shares — an estimated $4.84M sold.

Beck Bode LLC first reported a position in CLB in Q3 2020 and held it in 2 quarters. The position peaked at $4.84M in Q1 2023. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Beck Bode LLC reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Beck Bode LLC sold 219,503 Core Laboratories shares in Q2 2023, an estimated $4.84M.
  • Beck Bode LLC first reported a position in Core Laboratories in Q3 2020 and held it in 2 quarters.
  • Beck Bode LLC's Core Laboratories position peaked at $4.84M in Q1 2023.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Beck Bode LLC's 13F filing for Q2 2023, filed 10 Aug 2023.